Related Experiment Video
Updated: May 18, 2026
06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Spatial working memory impairment in subclinical hypothyroidism: an FMRI study.
Jing-Jing Yin1, Ling-Min Liao, Dong-Xue Luo
1First Affiliated Hospital, Medical College of Shantou University, Shantou, China.
Neuroendocrinology
|September 19, 2012
Summary
Subclinical hypothyroidism (SCH) impairs spatial working memory and alters brain activity, particularly in the right prefrontal and parietal lobes. Levothyroxine (LT4) treatment effectively reverses these memory deficits and normalizes brain network function.
Area of Science:
- Neuroscience
- Endocrinology
- Cognitive Psychology
Background:
- Subclinical hypothyroidism (SCH) is associated with cognitive deficits.
- Previous research indicated verbal working memory impairment in SCH patients.
Purpose of the Study:
- To investigate the neural basis of spatial working memory (SWM) impairment in SCH patients.
- To explore the effects of levothyroxine (LT4) treatment on SWM and associated neural activity.
Main Methods:
- Block-designed BOLD-fMRI was used to scan 16 SCH patients (before and after 6 months of LT4 treatment) and 16 matched euthyroid controls.
- Participants performed an n-back task to assess spatial working memory performance and brain activation patterns.
Main Results:
- SCH patients exhibited impaired spatial working memory with altered activation in key brain regions, including the dorsolateral prefrontal cortex (DLPFC) and parietal lobe (PA), showing right-hemisphere dominance.
- Reduced activation intensity and load effects were observed in SCH patients compared to controls.
- Following 6 months of LT4 treatment, SCH patients showed normalized brain activity and load effects across all regions of interest, comparable to euthyroid subjects.
Conclusions:
- SCH is linked to spatial working memory deficits, potentially due to altered neural activity in the right DLPFC and posterior parietal lobe.
- Levothyroxine (LT4) replacement therapy effectively improves spatial working memory and restores normal brain network function in SCH patients.
